169 related articles for article (PubMed ID: 1644924)
1. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen.
Ge Q; Frank MB; O'Brien C; Targoff IN
J Clin Invest; 1992 Aug; 90(2):559-70. PubMed ID: 1644924
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex.
Alderuccio F; Chan EK; Tan EM
J Exp Med; 1991 Apr; 173(4):941-52. PubMed ID: 2007859
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein.
Blüthner M; Bautz FA
J Exp Med; 1992 Oct; 176(4):973-80. PubMed ID: 1383382
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein components reactive with anti-PM/Scl autoantibodies.
Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
[TBL] [Abstract][Full Text] [Related]
5. Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen.
Ge Q; Wu Y; James JA; Targoff IN
Arthritis Rheum; 1996 Sep; 39(9):1588-95. PubMed ID: 8814071
[TBL] [Abstract][Full Text] [Related]
6. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the specificity of anti-PM-Scl autoantibodies.
Ge Q; Wu Y; Trieu EP; Targoff IN
Arthritis Rheum; 1994 Oct; 37(10):1445-52. PubMed ID: 7945469
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
[TBL] [Abstract][Full Text] [Related]
9. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
[TBL] [Abstract][Full Text] [Related]
10. Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides.
Blüthner M; Mahler M; Müller DB; Dünzl H; Bautz FA
J Mol Med (Berl); 2000; 78(1):47-54. PubMed ID: 10759029
[TBL] [Abstract][Full Text] [Related]
11. Isolation of cDNA clones encoding the 80-kd subunit protein of the human autoantigen Ku (p70/p80) by antisera raised against ciliary processes of human eye donors.
Hong TJ; Escribano J; Coca-Prados M
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4023-30. PubMed ID: 7960584
[TBL] [Abstract][Full Text] [Related]
12. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
Brouwer R; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
[TBL] [Abstract][Full Text] [Related]
13. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries.
Blüthner M; Bautz EK; Bautz FA
J Immunol Methods; 1996 Nov; 198(2):187-98. PubMed ID: 8946014
[TBL] [Abstract][Full Text] [Related]
14. The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus.
Raijmakers R; Egberts WV; van Venrooij WJ; Pruijn GJ
J Biol Chem; 2003 Aug; 278(33):30698-704. PubMed ID: 12788944
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.
Ge Q; Nilasena DS; O'Brien CA; Frank MB; Targoff IN
J Clin Invest; 1995 Oct; 96(4):1730-7. PubMed ID: 7560064
[TBL] [Abstract][Full Text] [Related]
16. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Mahler M; Fritzler MJ
Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
Reimer G; Scheer U; Peters JM; Tan EM
J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125
[TBL] [Abstract][Full Text] [Related]
18. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
19. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
20. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
